Can Bald Men Regrow Hair? The Science Explained

Many men with pattern baldness can regrow a meaningful amount of hair, but how much depends heavily on how far the loss has progressed. Thinning hair responds far better to treatment than a fully smooth scalp, and the biological reason for that gap is one of the more interesting findings in hair science over the past decade. The treatments available today range from cheap daily pills to surgical transplants, with several newer options filling in the space between.

Why Hair Miniaturizes in the First Place

Male pattern baldness is driven by dihydrotestosterone, or DHT, a hormone your body makes from testosterone. In scalp follicles that are genetically sensitive to it, DHT activates androgen receptors and gradually shrinks the follicle, a process called miniaturization. Over time, thick terminal hairs are replaced by fine, nearly invisible vellus hairs, and eventually the follicle may stop producing visible hair altogether.1PubMed. Dihydrotestosterone-induced hair regrowth inhibition by activating androgen receptor in C57BL6 mice simulates androgenetic alopecia

The damage is not just hormonal. DHT appears to co-mediate tissue changes around the follicle itself, including thickening of the dermal sheath, fibrosis, and even calcification of the surrounding tissue. These changes physically restrict the follicle’s growth space and choke off its oxygen and nutrient supply, which helps explain why hair loss is slow, persistent, and progressively harder to reverse the longer it continues.2PubMed. A hypothetical pathogenesis model for androgenic alopecia: clarifying the dihydrotestosterone paradox and rate-limiting recovery factors

Stem Cells Survive, but Progenitor Cells Disappear

One of the most encouraging findings in baldness research is that the stem cells responsible for generating new hair are retained in bald scalp. A landmark study found that hair follicle stem cells were maintained even in areas of advanced baldness.3PubMed Central. Bald scalp in men with androgenetic alopecia retains hair follicle stem cells but lacks CD200-rich and CD34-positive hair follicle progenitor cells That matters because it means the biological “seed” for hair growth has not been destroyed. The problem is further downstream: the progenitor cells that normally receive signals from those stem cells and actually build a new hair shaft are depleted or absent in fully bald areas.

More recent work from Indian patients confirmed this gradient. Partially bald areas still retained progenitor cells, but completely bald areas did not.4PubMed Central. Partial Alopecia Area Retains Bulge Hair Follicle Progenitor Cells in Indian Androgenetic Alopecia Patients This is the biological basis for the practical reality every dermatologist communicates: catching hair loss early, while miniaturized follicles still contain those progenitor cells, dramatically improves treatment outcomes. Once the scalp has been slick and smooth for years, the available medical therapies have much less to work with.

FDA-Approved Medications

The two mainstream drug classes for pattern hair loss attack the problem from different angles. Minoxidil (sold as Rogaine and generics) is a topical treatment that works partly by shortening the resting phase of the hair cycle, pushing dormant follicles back into their active growth phase sooner. It also appears to enlarge miniaturized follicles over time.5PubMed. Minoxidil: mechanisms of action on hair growth Minoxidil does not touch the hormonal cause of baldness. It keeps existing follicles producing thicker, longer-lasting hairs for as long as you keep using it, but the effects fade if you stop.

Finasteride (Propecia) takes the hormonal route. It blocks the enzyme that converts testosterone into DHT, lowering scalp DHT levels substantially. Dutasteride goes further by blocking both forms of that enzyme, whereas finasteride blocks only one.6PubMed. Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study A randomized trial comparing the two found that dutasteride at 2.5 mg increased hair count more than finasteride, with the difference visible by 12 weeks and maintained at 24 weeks.7PubMed. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride Dutasteride is approved for hair loss in some countries but is used off-label for that purpose in others, including the United States.

Both finasteride and dutasteride carry a risk of sexual side effects, including reduced libido and erectile difficulty, that puts some men off the treatment. These side effects are uncommon but real, and they drive a lot of the interest in topical alternatives and newer drugs.

Combination Approaches That Outperform Monotherapy

Using minoxidil and a DHT blocker together makes biological sense: one stimulates the follicle directly while the other reduces the hormone that is damaging it. The clinical data backs this up. A trial comparing topical finasteride 0.25% combined with minoxidil 5% found the combination significantly outperformed minoxidil alone, with an efficacy rate of about 87% for the combination versus 69% for minoxidil by itself.8Journal of Drugs in Dermatology. Efficacy of Topical Finasteride 0.25% With Minoxidil 5% Versus Topical Minoxidil 5% Alone in Treatment of Male Pattern Androgenic Alopecia A separate pilot study confirmed the advantage, finding that the combination produced greater terminal hair density by 24 weeks than either topical finasteride or minoxidil used alone.9PubMed Central. Comparative Efficacy of Topical Finasteride (0.25%) in Combination with Minoxidil (5%) Against 5% Minoxidil or 0.25% Finasteride Alone in Male Androgenetic Alopecia

The appeal of topical finasteride is that it delivers the DHT-blocking effect to the scalp while reducing how much of the drug reaches the rest of the body, which in theory lowers the risk of the sexual side effects associated with oral finasteride. Combination topical products are becoming increasingly common in dermatology clinics and through compounding pharmacies.

Microneedling Adds a Physical Boost

Microneedling involves rolling or stamping tiny needles across the scalp to create controlled micro-injuries. The idea is that the wound-healing response releases growth factors and increases blood flow, making the scalp more receptive to topical treatments. The evidence for combining microneedling with minoxidil is surprisingly strong. A pilot study found that men in the microneedling-plus-minoxidil group gained an average of about 91 new hairs in the target area over 12 weeks, compared to about 22 for minoxidil alone. More than 80% of the microneedling group reported over 50% improvement, versus under 5% in the minoxidil-only group.10PubMed Central. A Randomized Evaluator Blinded Study of Effect of Microneedling in Androgenetic Alopecia: A Pilot Study

A more recent meta-analysis of multiple randomized trials confirmed these findings, showing that combined microneedling therapy significantly improved both hair count and hair diameter compared to minoxidil alone.11PubMed Central. Evaluating the efficacy and safety of combined microneedling therapy versus topical Minoxidil in androgenetic alopecia: a systematic review and meta-analysis One smaller trial showed the difference in raw numbers clearly: the combination group gained about 12.5 hairs per square inch in the target area, while the minoxidil-only group gained under 2.12PubMed Central. A Randomized Controlled, Single-Observer Blinded Study to Determine the Efficacy of Topical Minoxidil plus Microneedling versus Topical Minoxidil Alone in the Treatment of Androgenetic Alopecia Microneedling is inexpensive and can be done at home with a dermaroller, though clinical-grade devices with longer needle lengths tend to produce better results.

Low-Level Light Therapy

Low-level light therapy (LLLT) uses red-light or near-infrared laser devices, often shaped like combs, helmets, or caps, to stimulate follicle activity. The largest controlled trials have shown statistically significant increases in terminal hair count for both men and women, and at least one study found that LLLT had similar effectiveness to minoxidil on its own. Combining LLLT with minoxidil and finasteride appeared to enhance results further.13PubMed Central. Role of Low-Level Light Therapy (LLLT) in Androgenetic Alopecia An evidence review found FDA-cleared LLLT devices to be safe and effective for patients who did not respond to or could not tolerate standard treatments.14PubMed. Low level laser therapy and hair regrowth: an evidence-based review

The effect size of LLLT alone is modest compared to medications, but it carries essentially no systemic side effects. For men who want to avoid pills or who are stacking multiple treatments, it is a reasonable addition.

Platelet-Rich Plasma Injections

Platelet-rich plasma (PRP) therapy involves drawing a small amount of your own blood, concentrating the platelets, and injecting that concentrate into the scalp. The growth factors in platelets act on stem cells in the follicle’s bulge area and promote the development of new follicles and blood vessel growth.15PubMed Central. Platelet-rich plasma for androgenetic alopecia: A review of the literature and proposed treatment protocol A systematic review of 14 studies found PRP to be a useful therapeutic tool for hair loss without major side effects.16PubMed Central. Platelet-rich Plasma as a Potential Treatment for Noncicatricial Alopecias

PRP’s biggest limitation is inconsistency. There is no standard preparation protocol, which means the concentration of platelets and growth factors varies from clinic to clinic and even session to session. This probably explains why some studies show strong results while others are lukewarm. It is also not cheap, typically running hundreds of dollars per session with multiple sessions recommended. Insurance rarely covers it.

Hair Transplant Surgery

When regrowth is the explicit goal and the hair loss is too advanced for medications to make a cosmetic difference, surgical transplantation remains the most reliable option. The procedure moves DHT-resistant follicles from the back and sides of the head to the thinning or bald areas. There are two main techniques: follicular unit transplantation (FUT), which removes a strip of donor scalp, and follicular unit extraction (FUE), which harvests individual follicle groupings one at a time.

How well transplanted follicles survive is the key question. One study of about 1,780 follicles across four patients found a survival rate of roughly 86% for FUT grafts and about 61% for FUE grafts, though one patient with an unusually poor FUE result dragged that average down. Excluding that outlier, FUE survival was closer to 70%.17Hair Transplant Forum International. FUE vs. FUT-MD: Study of 1,780 Follicles in Four Patients A separate study of three patients with larger graft counts found the two techniques performed roughly the same, with FUE showing a slight edge of about 1% for graft yield and 6% for hair yield.18Hair Transplant Forum International. FUT vs. FUE Graft Survival: A Side-by-Side Study of 3 Patients Undergoing a Routine 2,000+ Graft Hair Transplantation The upshot is that both techniques work well in skilled hands, and the choice often comes down to whether you want to avoid a linear scar (FUE) or want maximum grafts in a single session (FUT).

Transplants do not stop ongoing hair loss. A man who gets a transplant at 30 may lose native hair around the transplanted follicles over the following decade, creating an unnatural-looking pattern unless he also uses medications to slow the process. Most surgeons recommend finasteride or minoxidil as maintenance therapy after a transplant.

What the Next Generation of Treatments Looks Like

Several research directions could change the landscape substantially within the next five to ten years. One of the most exciting involves JAK inhibitors, a class of drugs originally developed for autoimmune conditions. In alopecia areata, where the immune system attacks follicles, JAK inhibitors like tofacitinib and baricitinib have shown promising results.19PubMed Central. Role of janus kinase inhibitors in the treatment of alopecia areata More broadly, research has shown that inhibiting the JAK-STAT pathway can trigger rapid onset of hair growth in both mouse and human skin by activating hair follicle stem cell populations.20PubMed Central. Pharmacologic inhibition of JAK-STAT signaling promotes hair growth Whether this translates into an effective treatment for common pattern baldness, as opposed to autoimmune hair loss, is still being worked out.

Another frontier involves the Wnt/β-catenin signaling pathway, which plays a central role in hair follicle regeneration and cycling.21PubMed Central. Targeting Wnt/β-Catenin Pathway for Developing Therapies for Hair Loss Drugs that could safely activate this pathway in scalp follicles might be able to wake up dormant stem cells, but the same pathway is involved in cell growth elsewhere in the body, which raises safety questions that have kept progress cautious.

Perhaps the most ambitious work involves growing new hair follicles from scratch. Researchers demonstrated that human dermal papilla cells, the signaling cells at the base of each follicle, can be cultured in three-dimensional spheroids that partially restore their ability to induce new hair follicle formation when transplanted into human skin.22PubMed Central. Microenvironmental reprogramming by three-dimensional culture enables dermal papilla cells to induce de novo human hair-follicle growth This is the holy grail: generating an unlimited supply of new follicles rather than just shuffling existing ones around the scalp. It remains experimental, but the proof of concept exists.

Clascoterone is a topical androgen receptor inhibitor that works differently from finasteride. Instead of reducing how much DHT your body makes, it blocks DHT from binding to its receptor directly at the follicle. It shares a similar molecular structure with DHT, which lets it compete for the same binding sites.23Oxford Academic. Clascoterone as a novel treatment for androgenetic alopecia Already approved for acne under the brand name Winlevi, clascoterone is being studied for pattern hair loss and could offer a topical alternative for men who want to target androgens without taking a systemic pill.

Supplements and Nutritional Factors

Hair supplement marketing is a multi-billion-dollar industry, and most of it overpromises. Nutrient deficiencies can absolutely cause or worsen hair loss, but in men with pattern baldness, the cause is hormonal and genetic, not nutritional. Correcting a genuine iron, zinc, or vitamin D deficiency may improve hair health broadly, but it will not reverse DHT-driven miniaturization.

Saw palmetto is the supplement with the most relevant evidence. A systematic review of five randomized trials and two cohort studies found that supplements containing saw palmetto showed improvements in hair quality, hair count, and density in people with pattern hair loss. Results ranged from about a 27% improvement in total hair count to stabilized disease progression in roughly half of users.24PubMed Central. Natural Hair Supplement: Friend or Foe? Saw Palmetto, a Systematic Review in Alopecia The effect is real but modest, and the review noted that robust high-quality data are still lacking. Saw palmetto is thought to work through mild DHT inhibition, which puts it in the same mechanistic lane as finasteride but at much lower potency.

Scalp Micropigmentation as a Non-Regrowth Option

Not every man with hair loss wants to chase regrowth. Scalp micropigmentation (SMP) is a cosmetic tattoo technique that deposits pigment into the scalp in a stippled pattern to simulate the look of a closely cropped buzz cut. It does not grow hair, but it eliminates the visual contrast between bare skin and surrounding hair that makes thinning so noticeable. For men with diffuse thinning, it can reduce the see-through appearance; for those who are fully bald, it creates a realistic shaved-head look with a defined hairline. The potential downside is that if hair loss continues to progress around the tattooed area, the illusion can become less convincing over time.25PubMed Central. Perceptions and Experiences of Scalp Micropigmentation Among Dermatology Outpatients With Hair Loss: A Survey-Based Study

Managing Expectations and Psychological Impact

Hair loss is often dismissed as a cosmetic concern, but its psychological effects are well documented. Common emotional responses include self-consciousness, embarrassment, frustration, and jealousy, and hair thinning can significantly affect how someone perceives their own body and identity.26PubMed Central. Psychology of Hair Loss Patients and Importance of Counseling That emotional weight can drive men toward aggressive treatment plans, which makes expectation management especially important.

A systematic review on the psychological consequences of pattern baldness found that clinical severity does not necessarily match how distressed someone feels about their hair loss. Two men at the same stage of baldness can experience completely different levels of psychological impact.27PubMed Central. The psychological consequences of androgenetic alopecia: A systematic review Unrealistic expectations about treatment outcomes can lead to worse psychological outcomes and premature abandonment of therapies that were actually working. The honest framing is that current treatments can meaningfully improve hair density in most men who start early enough, but they rarely produce a full restoration, and they usually require ongoing use to maintain results. Understanding that going in makes the whole process less stressful and more sustainable.